Company / Financials
PharmaCyte Biotech, Inc. Financials
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$0
FY2025
Net Income
$333.8K
FY2025 · +107.7% YoY
Profit Margin
-
FY2025 · net income / revenue
ROE
1.2%
FY2025 · return on equity
Total Assets
$55.2M
FY2025
Total Debt
-
FY2025
Equity
$27.6M
FY2025
ROA
0.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$0Net Income HistoryProfit after all expenses and taxes$333.8K+107.7% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$8.5M-32.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$6.1M+449.4% YoYR&D Expense HistoryResearch and development spending$407.4K-13.0% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$1.80-718.2% YoY